adult medulloblastoma
Showing 1 - 25 of >10,000
Ependymoma, Glioblastoma, Medulloblastoma Trial in Duarte (IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR
Recruiting
- Ependymoma
- +3 more
- IL13Ralpha2-specific Hinge-optimized 41BB-co-stimulatory CAR Truncated CD19-expressing Autologous T-Lymphocytes
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 9, 2022
Testing Cerebrospinal Fluid for Cell-free Tumor DNA in Children,
Not yet recruiting
- Anaplastic Astrocytoma
- +17 more
- (no location specified)
Jun 28, 2023
Brain Tumor, Pediatric, Medulloblastoma, Childhood, Embryonal Tumor Trial (GD2-CART01 (iC9-GD2-CAR T-cells))
Not yet recruiting
- Brain Tumor, Pediatric
- +6 more
- GD2-CART01 (iC9-GD2-CAR T-cells)
- (no location specified)
Mar 18, 2022
Adult Medulloblastoma, Childhood Medulloblastoma, Neuroblastoma Trial in Iowa City (drug, procedure, radiation)
Completed
- Adult Medulloblastoma
- +4 more
- gallium Ga 68-edotreotide
- +4 more
-
Iowa City, IowaUniversity of Iowa Hospitals and Clinics
Aug 26, 2021
High Grade Glioma, Meningioma, Embryonal Tumor Trial in United States (LUTATHERA® (Lutetium Lu 177 dotatate))
Recruiting
- High Grade Glioma
- +12 more
- LUTATHERA® (Lutetium Lu 177 dotatate)
-
Aurora, Colorado
- +8 more
Jan 16, 2023
CNS Tumors, Glioblastoma, Gliosarcoma, Adult Trial run by the (ONC206)
Recruiting
- Central Nervous System Neoplasms
- +22 more
-
Bethesda, MarylandNational Institutes of Health
Mar 1, 2022
Medulloblastoma, Neuroectodermal Tumor Trial in Los Angeles, Washington, Gainesville (TTRNA-xALT, TTRNA-DCs)
Active, not recruiting
- Medulloblastoma
- Neuroectodermal Tumor
- TTRNA-xALT
- TTRNA-DCs
-
Los Angeles, California
- +2 more
Jan 7, 2022
Neuroblastoma, Medulloblastoma Trial in United States (TPI 287)
Terminated
- Neuroblastoma
- Medulloblastoma
- TPI 287
-
San Diego, California
- +7 more
Apr 20, 2022
Rare CNS Tumors Outcomes &Risk
Recruiting
- High Grade Meningioma
- +4 more
-
Bethesda, MarylandNational Cancer Institute (NCI)
Jul 6, 2022
Medulloblastoma, Glioblastoma Multiforme, Anaplastic Astrocytoma Trial in Buffalo, New York, Cincinnati (SurVaxM for patients
Recruiting
- Medulloblastoma
- +7 more
- SurVaxM for patients with relapsed or progressive MB, HGG or ependymoma ages ≥10 and ≤21 years
- +2 more
-
Buffalo, New York
- +2 more
Jul 8, 2022
Brain and CNS Tumors Trial in Australia, Canada, United States (biological, drug, procedure, radiation)
Active, not recruiting
- Brain and Central Nervous System Tumors
- filgrastim
- +5 more
-
Durham, North Carolina
- +8 more
Dec 17, 2021
Brain and CNS Tumors, Intraocular Melanoma, Lung Cancer Trial in New York (genetic, other, radiation)
Active, not recruiting
- Brain and Central Nervous System Tumors
- +9 more
- DNA analysis
- +4 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Oct 28, 2021
Untreated Childhood Medulloblastoma Trial in Worldwide (drug, radiation, other)
Active, not recruiting
- Untreated Childhood Medulloblastoma
- Cisplatin
- +8 more
-
Birmingham, Alabama
- +177 more
Feb 25, 2022
Posterior Fossa Tumor, Medulloblastoma, Childhood Trial in Cairo (Pilates Core Stability Exercises program, Balance Program,
Completed
- Posterior Fossa Tumor
- Medulloblastoma, Childhood
- Pilates Core Stability Exercises program
- +2 more
-
Cairo, EgyptChildren's Cancer Hospital Egypt 57357
Aug 3, 2021
Advanced Cancer, Brain Metastases Trial in New Orleans (DM-CHOC-PEN)
Completed
- Advanced Cancer
- Brain Metastases
-
New Orleans, LouisianaTulane University Medical Center
Nov 3, 2022
CNS Tumor, Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma Trial in Seattle (SCRI-CARB7H3(s); B7H3-specific chimeric
Recruiting
- Central Nervous System Tumor
- +10 more
- SCRI-CARB7H3(s); B7H3-specific chimeric antigen receptor (CAR) T cel
-
Seattle, WashingtonSeattle Children's Hospital
Dec 14, 2022
Cerebellar Ataxia Trial in Giza (motor imaginary training, physical therapy training)
Completed
- Cerebellar Ataxia
- motor imaginary training
- physical therapy training
-
Giza, EgyptReham Alsakhawi
Aug 7, 2023
Brain and CNS Tumors, Radiation Toxicity Trial in United States (dietary supplement, drug, procedure)
Completed
- Brain and Central Nervous System Tumors
- Radiation Toxicity
- EGb761
- +2 more
-
Phoenix, Arizona
- +3 more
Sep 7, 2021
Medulloblastoma, Medulloblastoma, Childhood, Medulloblastoma Recurrent Trial in United States (Specialized Tumor Board Treatment
Recruiting
- Medulloblastoma
- +2 more
- Specialized Tumor Board Treatment Plan
-
San Diego, California
- +3 more
Dec 28, 2022
Neuroblastoma, Medulloblastoma Trial in United States (Nifurtimox, Cyclophosphamide, Topotecan)
Completed
- Neuroblastoma
- Medulloblastoma
- Nifurtimox
- +2 more
-
San Diego, California
- +14 more
Dec 28, 2022
Relapsed Solid Tumor, Refractory Solid Tumor Trial in Worldwide (Abemaciclib, Irinotecan, Temozolomide)
Recruiting
- Relapsed Solid Tumor
- Refractory Solid Tumor
- Abemaciclib
- +4 more
-
Phoenix, Arizona
- +28 more
Dec 7, 2022
Medulloblastoma, Childhood, Cognitive Impairment Trial (Metformin HCl (HCl) 500mg tablet, Placebo)
Recruiting
- Medulloblastoma, Childhood
- Cognitive Impairment
- Metformin hydrochloride (HCl) 500mg tablet
- Placebo
-
New Lambton Heights, New South Wales, Australia
- +15 more
Sep 7, 2022
Medulloblastoma Trial in Houston (Treatment with MTX110)
Recruiting
- Medulloblastoma
- Treatment with MTX110
-
Houston, TexasThe University of Texas Health Science Center at Houston
Jun 30, 2022